494 related articles for article (PubMed ID: 9017785)
1. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid metabolites: mediators of inflammation in asthma.
Wenzel SE
Pharmacotherapy; 1997; 17(1 Pt 2):3S-12S. PubMed ID: 9017783
[TBL] [Abstract][Full Text] [Related]
3. The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma.
Sorkness CA
Pharmacotherapy; 1997; 17(1 Pt 2):50S-54S. PubMed ID: 9017788
[TBL] [Abstract][Full Text] [Related]
4. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
Leff AR
Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
6. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
Hendeles L
Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
[No Abstract] [Full Text] [Related]
7. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
[TBL] [Abstract][Full Text] [Related]
8. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
Wagener M
Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
[TBL] [Abstract][Full Text] [Related]
9. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
10. Role of leukotrienes in asthma.
Henderson WR
Ann Allergy; 1994 Mar; 72(3):272-8. PubMed ID: 8129221
[TBL] [Abstract][Full Text] [Related]
11. Moderating the inflammation of asthma: inhibiting the production or action of products of the 5-lipoxygenase pathway.
Israel E
Ann Allergy; 1994 Mar; 72(3):279-84. PubMed ID: 8129222
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene modifiers for asthma treatment.
Montuschi P; Peters-Golden ML
Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
[TBL] [Abstract][Full Text] [Related]
13. [The anti-leukotrienes: their use in asthma].
Devillier P; Millart H; Advenier C
Rev Med Brux; 1997 Sep; 18(4):279-85. PubMed ID: 9411661
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene inhibitors and antagonists in asthma.
Spector SL
Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):463-70, 473; quiz 473-4. PubMed ID: 8603274
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
16. Anti-leukotriene agents: a new direction in asthma therapy.
Nathan RA
J Asthma; 1996; 33(6):353-66. PubMed ID: 8968291
[TBL] [Abstract][Full Text] [Related]
17. [Role of peptide-leukotrienes in bronchial asthma].
Kohno S
Nihon Yakurigaku Zasshi; 1998 Apr; 111(4):223-31. PubMed ID: 9618707
[TBL] [Abstract][Full Text] [Related]
18. The role and contribution of leukotrienes in asthma.
Busse W
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):17-26; quiz 26-9. PubMed ID: 9690569
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
Montuschi P; Sala A; Dahlén SE; Folco G
Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin.
Werz O
Planta Med; 2007 Oct; 73(13):1331-57. PubMed ID: 17939102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
